Skip to main content
OCUL logo

OCUL · Ocular Therapeutix, Inc · Executive Compensation

Track OCUL — free
$5.99 +0.05 (+0.84%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.31B
Shares
220.02M
Volume · Nov 19 205.83K Avg daily vol (3M) 3.04M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Seung Suh Hong, Ph.D.
“Dr. Hong’s resignation is not the result of any disagreement with the Board or with management on any matter relating to the Company’s operations, policies or practices.”
Resigned 2026-11-09
Riad Sherif, M.D. Appointed 2026-11-09
Sanjay Nayak, M.B.B.S., Ph.D. Resigned 2026-10-16
Jason Robins Appointed 2026-06-12
Jason Robins Appointed 2026-01-23
Leslie J. Williams Appointed 2025-06-11
Richard L. Lindstrom, M.D. Appointed 2025-06-11
Seung Suh Hong, Ph.D. Appointed 2025-06-11
Donald Notman Appointed 2024-09-03
Charles Warden Appointed 2024-06-14
Adrienne L. Graves, Ph.D. Appointed 2024-06-14
Rabia Gurses Ozden, M.D. Resigned 2024-04-18
Nadia Waheed, M.D. Appointed 2024-04-18
Antony C. Mattessich
“Mr. Mattessich's resignation was not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2024-04-18
Pravin U. Dugel, M.D. Appointed 2024-04-18
Peter Kaiser Appointed 2024-02-22
Sanjay Nayak Appointed 2024-02-22
Jeffrey S. Heier Appointed 2024-02-22
Jeffrey S. Heier
“At the time of his resignation, Dr. Heier informed the Company that his resignation was not based upon any disagreement with the Board, or with the management of the Company, on any matter relating to the Company’s operations, policies or practices.”
Resigned 2024-02-22
Pravin U. Dugel Appointed 2024-02-22
Pravin U. Dugel Appointed 2024-02-22
Adrienne L. Graves, Ph.D. Appointed 2023-07-12
Merilee Raines Appointed 2023-06-16
Jeffrey S. Heier, M.D. Appointed 2023-06-16
Leslie J. Williams Appointed 2022-06-17

Leadership

Key facts CIK 1393434 CUSIP 67576A100 13F (30d) 269 filings 250 filers Visit website Investor relations